1 Min Read
March 20 (Reuters) - Mayne Pharma Group Ltd:
* ABBREVIATED NEW DRUG APPLICATION FOR GENERIC NUVARING HAS BEEN ACCEPTED FOR FILING BY US FOOD AND DRUG ADMINISTRATION Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.